Pharmaceuticals and medicine are extremely significant areas of the German economy, both for the domestic and the export market. Companies active in this sector can be confident that we have many years of experience and can provide top-notch, solid advice in this area. Our practice includes such matters as spin-offs from pharmaceutical companies, licensing and distributorship agreements, development and approval of new drugs, contract manufacturing, quality assurance agreements, financing agreements with funding providers and investors, structuring and safeguarding the relevant technology transfer, as well as agreements with CROs. BMT’s experience with pharmaceutical sector M&As rounds out its overall spectrum of expertise in this area.
BMT offers top-calibre legal advice covering the entire spectrum of the healthcare business – from the initial idea, to product development, to market success. This also includes, in particular, advice to entrepreneurs whose policy and business convictions require them to defend against constantly increasing regulatory interference in the healthcare sphere, which is causing more and more harm to Germany’s historic reputation as the “world’s pharmacist”.
BMT advises and represents innovative research, development and commercial entities in the areas of pharmaceuticals, biotechnology and medical technology. Our clients benefit in many ways from BMT’s good contacts and working relationships with large research institutions and venture capitalists in this sector.
We support our clients by ensuring that the desired business outcome meshes with what the law permits, and then we find the best organisational form for the solutions we have crafted. BMT focuses particularly on advising and supporting organisational and restructuring processes, public-private-partnerships and privatisation models for hospitals, and we advise physicians and/or hospitals on the various forms of cooperation available.